A Galician Lung Cancer Group phase II study: Erlotinib as maintenance therapy after concurrent chemoradiotherapy in patients (p) with stage III non-small cell lung cancer (NSCLC).
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7091-7091
◽
Keyword(s):
Phase Ii
◽
2013 ◽
Vol 73
(3)
◽
pp. 451-457
◽